MG
FLGT icon

Michael Gelband’s Fulgent Genetics FLGT Stock Holding History

Michael Gelband’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$966K Buy
+47,087
New +$798K 0.01% 1087
2026
Q1 		– Sell
-13,975
Closed -$367K – 1728
2025
Q4 		$367K Buy
+13,975
New +$363K ﹤0.01% 1260
2025
Q3 		– Sell
-38,494
Closed -$765K – 1694
2025
Q2 		$765K Buy
+38,494
New +$750K 0.01% 1040
2025
Q1 		– Sell
-92,197
Closed -$1.7M – 1641
2024
Q4 		$1.7M Buy
92,197
+39,618
+75% +$773K 0.01% 772
2024
Q3 		$1.14M Sell
52,579
-40,202
-43% -$899K 0.01% 932
2024
Q2 		$1.82M Buy
+92,781
New +$1.94M 0.01% 817
2024
Q1 		– Sell
-20,079
Closed -$580K – 1639
2023
Q4 		$580K Sell
20,079
-2,025
-9% -$54.2K ﹤0.01% 992
2023
Q3 		$591K Buy
22,104
+135
+0.6% +$4.61K 0.01% 1177
2023
Q2 		$814K Sell
21,969
-61,858
-74% -$2.16M 0.01% 1182
2023
Q1 		$2.62M Buy
+83,827
New +$2.7M 0.02% 774
2022
Q4 		– Sell
-13,303
Closed -$507K – 1781
2022
Q3 		$507K Sell
13,303
-10,402
-44% -$521K 0.01% 1369
2022
Q2 		$1.29M Buy
23,705
+16,333
+222% +$898K 0.02% 961
2022
Q1 		$460K Buy
7,372
+4,086
+124% +$269K 0.01% 1580
2021
Q4 		$331K Buy
+3,286
New +$289K ﹤0.01% 1618
2020
Q2 		– Sell
-33,728
Closed -$363K – 1850
2020
Q1 		$363K Sell
33,728
-107
-0.3% -$1.49K 0.02% 593
2019
Q4 		$436K Buy
+33,835
New +$402K 0.01% 941

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's FLGT Position: Q2 2026 in Review

Michael Gelband opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 47,087 shares worth $966K. The stake represents 0.01% of the portfolio and ranks #1087 among its holdings. This is a return to the name: Michael Gelband previously reported a position in FLGT as recently as Q4 2025.

Michael Gelband first reported a position in FLGT in Q4 2019 and has held it in 16 quarters since. The position peaked at $2.62M in Q1 2023. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Michael Gelband held 47,087 shares of Fulgent Genetics worth $966K as of Q2 2026.
  • Fulgent Genetics was a new Michael Gelband position in Q2 2026.
  • Fulgent Genetics made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1087 holding.
  • Michael Gelband first reported a position in Fulgent Genetics in Q4 2019 and has held it in 16 quarters since.
  • Michael Gelband's Fulgent Genetics position peaked at $2.62M in Q1 2023.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.